Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Rochester, MN · hospital | United States | 0 | 4,572 | 48,202 | #5 | ||
Boston · cancer center | United States | 1 | 4,333 | 74,896 | none recorded | #15 | |
San Francisco · cancer center | United States | 0 | 2,818 | 47,444 | #33 | ||
Candiolo · cancer center | Italy | none recorded | 0 | 324 | 4,466 | - | |
Frederick, MD · government | United States | none recorded | 0 | 318 | 4,032 | - | |
Glasgow · cancer center | United Kingdom | none recorded | 0 | 258 | 2,699 | - | |
Madrid · research institute | Spain | none recorded | 0 | 201 | 3,539 | - | |
Cambridge, MA · research institute | United States | 0 | 22 | 500 | - | ||
New York, NY · cancer center | United States | 0 | not matched | - | - | ||
Woodbury, NY · consortium | United States | none recorded | 0 | not matched | - | - | |
Phoenix, AZ · hospital | United States | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with KRAS G12C-mutant pancreatic ductal adenocarcinoma but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.